Early Aspirin administration post Coronary Artery Bypass Graft Surgery – Changing hospital culture through a two-cycled audit
Authors:
Open Access
- 10 March 2017
- journal article
- Published by BMJ in BMJ Quality Improvement Reports
- Vol. 6 (1)
Abstract
“Early Aspirin” or a medium dose of aspirin 6 hours after Coronary Artery Bypass Graft (CABG) Surgery is strongly recommend by international guidelines (EACTS 2007/AHA 2011 guidelines, Level1a evidence) to protect venous graft patency. However, compliance with Early Aspirin prescription at our centre is poor due to long standing hospital cultural practices and lack of awareness. We completed a two-cycled retrospective audit of 53 (September 2015 Baseline), 65 (January 2016 First Cycle) and 58 (June 2016 Second Cycle) consecutive CABG patients. Interval interventions included educational presentations, educational leaflets/posters, pharmacy liaison and modifications to e-prescription order-sets. Medical, nursing and pharmacy staff were involved in the audit strategies. Early aspirin prescription improved from 23% to 48% to 55% while administration of Early Aspirin improved from 17% to 38% and finally to 48% by second improvement cycle. Significantly, the proportion of patients with omission of early aspirin despite a clear clinical indication, decreased by 50% over the audit period. Important practical considerations were the last dose of anti-platelets preoperatively and amount of of bleeding from mediastinal drains post operatively. A multidisciplinary team based approach led to a 139% improvement in prescription and 182% improvement in administration of “Early Aspirin” after CABG surgery.Keywords
This publication has 10 references indexed in Scilit:
- Aspirin Reload Before Elective Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2014
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive SummaryCirculation, 2011
- Practice Considerations of Early Aspirin Administration following Coronary Artery Bypass SurgeryThe Heart Surgery Forum, 2011
- Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trialEuropean Heart Journal, 2010
- Guideline on antiplatelet and anticoagulation management in cardiac surgeryEuropean Journal of Cardio-Thoracic Surgery, 2008
- Aspirin and Mortality from Coronary Bypass SurgeryNew England Journal of Medicine, 2002
- ACC/AHA guidelines for coronary artery bypass graft surgeryJACC, 1999
- Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.1994
- Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapyBMJ, 1994
- Optimal antithrombotic therapy following aortocoronary bypass: A meta-analysisEuropean Journal of Cardio-Thoracic Surgery, 1993